Michael Morrissey

President and CEO, Exelixis

Alameda, California

About

Michael Morrissey, Ph.D., is the president and chief executive officer of Exelixis, Inc., an oncology company based in Alameda, California that develops cancer medicines. Exelixis' 2026 proxy statement says he has been a director and CEO since July 2010. The company's leadership page and its third-quarter 2026 results release name him as president and CEO.

Morrissey joined Exelixis in February 2000 and was president of research and development from January 2007 to July 2010. From 1991 to 2000 he held several positions at Berlex Biosciences, last as vice president of discovery research. Earlier he was a senior scientist and project team leader in medicinal chemistry at CIBA-Geigy. He holds a B.S. with honors in chemistry from the University of Wisconsin and a Ph.D. in chemistry from Harvard University. Other biopharmaceutical leaders with pages on Whoo include Reshma Kewalramani of Vertex and Robert Bradway of Amgen.

Whoo compiled this page from public sources: Exelixis leadership page, Exelixis third-quarter 2026 results release (SEC filing), Exelixis 2026 proxy statement (SEC filing). It is not affiliated with or endorsed by Michael Morrissey. Are you Michael Morrissey? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.

Want a page like this? Create yours from your résumé.

Experience

President and Chief Executive Officer — Exelixis


July 2010 – Present | Alameda, California

  • Director since July 2010
  • President of Research and Development — Exelixis


    January 2007 – July 2010

    Exelixis


    February 2000 – 2007

  • Held positions of increasing responsibility after joining
  • Berlex Biosciences


    1991 – 2000

  • Last role was vice president of discovery research

Senior Scientist and Project Team Leader, Medicinal Chemistry — CIBA-Geigy


Education

Ph.D. in Chemistry — Harvard University

B.S. (Honors) in Chemistry — University of Wisconsin


Projects